Ocular Hypotensive Efficacy and Safety of the Rho Kinase Inhibitor AR-12286 in Patients With Elevated Intraocular Pressure

被引:0
|
作者
Williams, R. D. [1 ]
Novack, G. D. [2 ]
van Haarlem, T. [3 ]
Kopczynski, C. [4 ]
机构
[1] Clin Res Ctr, Louisville, KY USA
[2] PharmaLog Dev Inc, San Rafael, CA USA
[3] Aerie Pharmaceut Inc, Bridgewater, NJ USA
[4] Aerie Pharmaceut Inc, Res Triangle Pk, NC USA
关键词
intraocular pressure; trabecular meshwork; clinical (human) or epidemiologic studies: treatment/prevention assessment/controlled clinical trials;
D O I
暂无
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
1633
引用
收藏
页数:2
相关论文
共 42 条
  • [41] Late-day intraocular pressure-lowering efficacy and tolerability of travoprost 0.004% versus bimatoprost 0.01% in patients with open-angle glaucoma or ocular hypertension: a randomized trial
    DuBiner, Harvey B.
    Hubatsch, Douglas A.
    BMC OPHTHALMOLOGY, 2014, 14
  • [42] Long-term intraocular pressure-lowering efficacy and safety of ripasudil-brimonidine fixed-dose combination for glaucoma and ocular hypertension: a multicentre, open-label, phase 3 study
    Tanihara, Hidenobu
    Yamamoto, Tetsuya
    Aihara, Makoto
    Koizumi, Noriko
    Fukushima, Atsuki
    Kawakita, Koji
    Kojima, Satoshi
    Nakamura, Toka
    Suganami, Hideki
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2024, 262 (08) : 2579 - 2591